Allen Wilbanks stands at the forefront of SABCS 2023, the setting for a conversation with…

At ASH 2023, Hamza Hashmi, MD, a medical doctor and hematologist from Charleston, South Carolina,…

In an interview, Andrew Evens, DO, an expert in hematology and oncology, will discuss a…

In a discussion on cancer science, Wassim Mchayleh, MD, explores the role of Minimal Residual…

By. Robert Rifkin, MDDate: 12/13/2023 Robert Rifkin, MD, a medical oncologist and hematologist at SCRI…

Wassim Mchayleh, MD, a speaker at the Medical Data and Analysis Symposium (MDAS), discusses the…

Evandro Bezerra, MD, hematologist and assistant professor at The Ohio State University Wexner Medical Center,…

Under the lights of ASH 2023, the microphone poised to capture insights, Dr. Lorenzo Falchi,…

Catherine Diefenbach, MD, a Hematologist and Medical Oncologist at NYU Langone Health, led a study…

Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…